Tricor is a lipid-lowering agent used to treat abnormal lipid levels in the bloodstream, including cholesterol and triglycerides. The product is available in 145mg and 48mg strengths.
Bill Wells, Biovail’s CEO, said: “This represents the second successful abbreviated new drug application (ANDA) filing in the past six months. While our primary focus remains the implementation of our new strategic focus, we continue to make progress with our existing pipeline products.”